Request Deal Involvement

Telix Pharmaceuticals completed the acquisition of the therapeutic assets and biologics technology platform of ImaginAb for $230m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Jefferies & Company

financial advisors

Jefferies & Company

Stifel

financial advisors

Stifel

or

Principals

IMAGINAB (THERAPEUTIC ASSETS AND BIOLOGICS TECHNOLOGY PLATFORM)

target

IMAGINAB (THERAPEUTIC ASSETS AND BIOLOGICS TECHNOLOGY PLATFORM)

TELIX PHARMACEUTICALS

bidder

TELIX PHARMACEUTICALS

IMAGINAB

vendor

IMAGINAB

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Telix Pharmaceuticals completed the acquisition of the therapeutic assets and biologics technology platform of ImaginAb for $230m.